Optum Senior Vice President and Chief Scientific Officer to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Optum Senior Vice President and Chief Scientific Officer to Deliver Keynote at Connected Health Summit: Engaging Consumers

DALLAS, TX--(Marketwired - Aug 28, 2014) -  Parks Associates announced today that Ronald J. Ozminkowski, Ph.D. , Senior Vice President and Chief Scientific Officer, Consumer Solutions Group, Optum, will present the keynote address "Enhancing the Consumer's Propensity to Succeed in a Digital Health Management World" at Connected Health Summit: Engaging Consumers at 11:45 a.m. on Friday, September 5, in San Diego. Ozminkowski will examine how technology providers can help consumers identify and reduce health-related risks and gaps in care that can adversely affect their quality of life.

Parks Associates' 2Q 2014 consumer survey data finds 18% of U.S. broadband households see a doctor who offers real-time video calls via the Internet and roughly 28% of them have used this feature. Forty percent see a provider who allows them to check specific medical exam results online, and over 50% of patients with this access have used this feature. Forty-two percent can view the medical history online, and over 50% of patients with this access have done so.

"A tall order from the Affordable Care Act (ACA) is to reshape the relationship between health providers and patients in the U.S. by more proactively engaging patients for self-care and healthy living," said Harry Wang , Director, Health & Mobile Product Research, Parks Associates. "Engaging consumers in healthcare requires solutions with the flexibility to align the various goals and values of individual consumers. Dr. Ozminkowski's keynote will provide invaluable insight on the role of healthcare technologies in motivating consumers toward their own best outcomes."

"For healthcare providers, they now have financial incentives to engage their patients in quality-enhancing services," Dr. Ozminkowski said. "They need to be able to guide and advise patients who ask questions about new apps or where best to get advice online or from other sources. Many individual providers will struggle with this transition, so services that can offer to help providers carry out care coordination and help manage the associated business aspects will be well received. I look forward to discussing this key market area at Connected Health Summit ."

Parks Associates will host the inaugural Connected Health Summit: Engaging Consumers on September 4-5 at the Omni Hotel in San Diego. The two-day executive conference will feature interactive panels focusing on the impact of connected devices, mobile health services, and new health reforms on service providers, connected device manufacturers, payors, and institutions in the digital health markets. In addition to Optum, the Connected Health Summit will feature keynotes from Qualcomm Life, Humana Wellness, Walgreens, and Ascension Health.

Connected Health Summit Sponsors include Association Sponsor CEA; Charter Sponsors ADT, Care Innovations, Lowe's, and Z-Wave; Registration Sponsor Independa; Special Event Sponsor Walgreens; Event Sponsor Masimo; and Break Sponsors Ayla Networks, Playtabase, and Wellness & Prevention, Inc., a Johnson & Johnson company.

Registration and the agenda can be found on the event website www.connectedhealthsummit.com . Press passes are available at http://www.parksassociates.com/events/connected-health/media . Contact Holly Sprague at hsprague@gmail.com for interviews or press inquiries.

About Connected Health Summit

Connected Health Summit: Engaging Consumers analyzes the roles of connected health technologies and innovations in driving changes in consumer behaviors and business models. The event focuses on four areas of consumer health technologies in particular, which all require active consumer participation to be successful: remote health monitoring for accountable care, consumer-centric wellness and fitness solutions, independent living technologies and services, and innovative convenience care models.

The Connected Health Summit: Engaging Consumers will take place September 4-5 at the Omni Hotel in San Diego, CA. www.connectedhealthsummit.com . Follow the event on Twitter at @CONN_Health_Smt. Subscribe to Parks Associates' digital health newsletter at http://www.parksassociates.com/newsletters_subscribe .

Holly Sprague Parks Associates 720.987.6614 hsprague@gmail.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Growth of Middle-Class Investors through Mutual Fund Ownership

Updated Category News Views 149

Mutual Funds and the Rise of the Middle-Class Investor Over recent years, mutual fund ownership has surged among middle-class families. According to insights from the Investment Company Institute (ICI), this trend signifies a vital transition as middle-income households increasingly seek investment opportunities. The growing presence of mutual funds in the American...

Continue Reading
Rques Exchange Reinforces Its Brand with Compliance Strategy

Updated Category News Views 180

Rques Exchange Reinforces Brand with Regulatory Frameworks Rques Exchange is taking significant steps to enhance its brand by emphasizing its commitment to regulatory alignment, operational transparency, and governance integrity in various markets. With global authorities increasingly scrutinizing digital asset platforms, Rques aims to position itself as a technology...

Continue Reading
Business Growth and Confidence: Provident Bank's Insights

Updated Category News Views 120

Increasing Business Confidence for the Future Recently, Provident Bank, a prominent financial institution based in New Jersey, conducted an enlightening Economic Outlook survey. This survey reflects the sentiments of 1,000 business leaders regarding the 2025 economic prospects. The results showcase a robust sense of optimism and confidence among businesses as they look...

Continue Reading
Performance Food Group Co: A Five-Year Stock Journey

Updated Category News Views 219

Unlocking the Value of Investment in Performance Food Group Co Performance Food Group Co (NYSE: PFGC) has delivered impressive returns over the last five years, standing out in the competitive market landscape. With an annualized return that has surpassed the market by 9.42%, investors have seen an average growth rate of around 24.5%. This stock is not just another entry...

Continue Reading
Understanding Rathbones Group Plc's Disclosure Requirements

Updated Category News Views 227

Key Information on Disclosure Requirements Understanding how companies disclose their shareholding is crucial for investors and stakeholders alike. Rathbones Group Plc plays an essential role in managing these disclosures, particularly regarding relevant securities that represent substantial interests in listed companies. Full Name of the Discloser The full name of the...

Continue Reading